Send me a link:

*Text messaging rates may apply.

 Dow Up0.13% Nasdaq Down0.10%

Covance Inc. (CVD)

87.34 Up 0.45(0.52%) 4:01PM EDT
ProfileGet Profile for:
Covance Inc.
210 Carnegie Center
Princeton, NJ 08540
United States - Map
Phone: 609-452-4440
Fax: 609-452-9375

Index Membership:N/A
Industry:Medical Laboratories & Research
Full Time Employees:11,863

Business Summary 

Covance Inc., a drug development services company, provides a range of early-stage and late-stage product development services to the pharmaceutical and biotechnology industries worldwide. It operates in two segments, Early Development and Late-Stage Development. The Early Development segment offers preclinical services, such as toxicology, pharmaceutical chemistry, nutritional chemistry and food safety, purpose-bred animals for biomedical research, lead optimization and translational services, and bioanalytical testing services. This segment also provides clinical pharmacology services, including first-in-human trials and early patient proof of concept studies of new pharmaceuticals at its clinics in the United States and the United Kingdom. The Late-Stage Development segment offers central laboratory services to biotechnology and pharmaceutical customers; and clinical development services, such as the full management of Phase II through IV clinical studies, study design and modeling, co-ordination of study activities, trial logistics, monitoring of study site performance, clinical data management and biostatistical analysis, and medical writing and regulatory services, as well as periapproval services. This segment also provides market access services, including reimbursement and healthcare economics consulting services, which comprise outcomes and pharmacoeconomic studies, reimbursement planning, reimbursement advocacy programs, risk evaluation and mitigation strategy services, registry services, specialty pharmacy services, and managed market contracting services; and clinical trial support services, such as interactive voice and Web response, and cardiac safety services. The company also provides laboratory testing services to the chemical, agrochemical, and food industries. Covance Inc. was founded in 1987 and is headquartered in Princeton, New Jersey.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on Covance Inc.

Corporate Governance 
Covance Inc.’s ISS Governance QuickScore as of Jul 1, 2014 is 2. The pillar scores are Audit: 1; Board: 1; Shareholder Rights: 5; Compensation: 2.
Brought to you by Institutional Shareholder Services (ISS)

Key Executives 
Mr. Joseph L. Herring , 58
Chairman and Chief Exec. Officer
Ms. Alison A. Cornell , 51
Chief Financial Officer and Corp. Sr. VP
Mr. William E. Klitgaard , 60
Chief Information Officer, Corp. Sr. VP and Treasurer
Mr. Richard F. Cimino , 54
Exec. VP and Group Pres of Clinical Devel.
Ms. Deborah L. Keller Tanner , 51
Exec. VP and Group Pres of R&D Laboratories
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders